Eastman Q3 2024: revenue up 9%, adj. EPS $2.26 vs $1.47 YoY; guidance midpoint unchanged

EASTMAN CHEMICAL CO

2024-Q3 EPS reported $4.86 revenue$7,137,000,000

Sales revenue $2.464B (+9% YoY); EBIT $329M vs $256M; adj. EBIT $366M.
Adj. diluted EPS $2.26 vs $1.47; reported EPS $1.53 vs $1.49.
Sales volume/mix up 8% across all segments; Chemical Intermediates revenue +13%.
Announced investment decision for second methanolysis facility in Longview, Texas.
FY2024 adj. EPS guidance maintained at $7.50-$7.70; cash from ops target ~$1.3B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.